Success Metrics

Active Trials
3(60%)

Phase Distribution

Ph phase_1
1
20%
Ph not_applicable
2
40%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Other(2)

Detailed Status

unknown2
Active, not recruiting2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting120%
unknown240%
active_not_recruiting240%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
RADIATION
Total Trials
5